Home/Filings/4/0000904454-14-000348
4//SEC Filing

HERON THERAPEUTICS, INC. /DE/ 4

Accession 0000904454-14-000348

$HRTXCIK 0000818033operating

Filed

Mar 27, 8:00 PM ET

Accepted

Mar 28, 6:20 PM ET

Size

5.5 KB

Accession

0000904454-14-000348

Insider Transaction Report

Form 4
Period: 2014-03-18
Gelder Mark S. MD
SVP & Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2014-03-18+100,000100,000 total
    Exercise: $15.18Exp: 2024-03-18Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]The Option vests and becomes exercisable only upon the achievement of a specified performance goal. The Option will be forfeited if the performance goal is not met by the applicable deadline.

Issuer

HERON THERAPEUTICS, INC. /DE/

CIK 0000818033

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000818033

Filing Metadata

Form type
4
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 6:20 PM ET
Size
5.5 KB